HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Pipeline

What actually drives speed in complex drug development programs

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.

By BioPharma Dive · Apr 20, 2026 · via BioPharma Dive
What actually drives speed in complex drug development programs

Image: BioPharma Dive

Tags
pipelineformat:headlineheadlineBioPharma Dive
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Pipeline
All Pipeline →
STAT+: AACR 2026: More strong data for Revolution Medicines’ KRAS drug
PipelineSTAT News ↗
STAT+: AACR 2026: More strong data for Revolution Medicines’ KRAS drug
You're reading the web version of STAT's popup newsletter, AACR in 30 seconds, your guide to what's happening …
Apr 19, 2026
Small pools, big ideas: How the rare disease community is reimagining clinical trials
PipelineFierceBiotech ↗
Small pools, big ideas: How the rare disease community is reimagining clinical trials
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
Apr 17, 2026
Qiagen launches latest diagnostic for bloodstream infections
PipelineFierceBiotech ↗
Qiagen launches latest diagnostic for bloodstream infections
Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.…
Apr 17, 2026